Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
IPO
Sort By
Newest First
1 / 1
1 / 1
Column: Investment
IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?
Danielle Alvarez
Pharma's Almanac
PAO-06-022--NI-02
June 24, 2022
Column: Investment
2021 Was a Great Year for Biotech IPOs, Depending on When You Got Out
Danielle Alvarez
Pharma's Almanac
PAO-03-022-NI-07
March 23, 2022
IPO
Erasca Announces Pricing of Upsized Initial Public Offering
Erasca
PR-M07-21-09
July 20, 2021
IPO
Zymergen Announces Pricing of Upsized Initial Public Offering
Zymergen
PR-M04-21-021
April 22, 2021
IPO
NeuroPace, Inc. Announces Pricing of Initial Public Offering
Nice Insight
PR-M04-21-022
April 21, 2021
IPO
GRAIL Announces Filing of Registration Statement for Proposed Initial Public Offering
GRAIL
PR-M09-20-NI-13-1304
September 09, 2020
Investment
Mirum Pharmaceuticals Files for IPO
Nice Insight
PAO-M07-19-NI-001
July 01, 2019
IPO
BridgeBio Pharma Announces Pricing of Its Initial Public Offering
BridgeBio Pharma
PR-M06-19-NI-060
June 28, 2019
IPO
Stealth BioTherapeutics Announces Pricing of Initial Public Offering
Stealth BioTherapeutics
PR-M02-19-NI-042
February 20, 2019
Investment
China SXT Pharmaceuticals, Inc. Announces Effectiveness of Registration Statement on Form F-1
China SXT Pharmaceuticals, Inc.
PR-M10-18-NI-017
October 04, 2018
Investment
The Biotech Boom
Emilie Branch
Pharma's Almanac
PAP-Q3-18-NI-003
October 02, 2018
IPO
Titan Pharmaceuticals Prices $9,500,000 Public Offering
Titan Pharmaceuticals
PR-M09-18-NI-093
September 28, 2018
